Max HealthcareQ1 FY25

Max Healthcare Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,030.9P/E: 70.6Market Cap: ₹1.0L CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 4

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Network gross revenue grew 18% YoY and 7% QoQ in Q1 FY25, indicating continued sales growth.
  • Occupancy increased to 77%, with occupied bed days growing ~5% YoY; volume growth expected with capacity expansions.
  • Brownfield expansions (e.g., Lucknow, Nagpur, Shalimar Bagh) will drive volume growth as new beds fill up, with up to 34-35% volume increases noted in expansions.
  • ARPOB growth is expected around 7-10% annually, driven by tariff revisions and higher-end procedures.
  • New hospitals currently have lower ARPOB (~Rs. 45,000) than existing hospitals (~Rs. 80,000), but expected to rise to Rs. 60,000-65,000 within a year.
  • International patient business is growing faster than other segments, increasing its revenue share.
  • Expansion plans will increase capacity by several hundred beds over next 1-2 years, supporting volume and revenue growth.
  • Overall, steady-state growth rates in existing hospitals’ inpatient volumes are expected in high single digits.

See what Max Healthcare management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • All the ongoing and planned expansions are being funded through internal accruals.
  • The company pursues asset-light models such as built-to-suit with long-term leases to limit upfront capital expenditure.
  • For example, the Mohali hospital is a 50-year lease model where the developer incurs the project cost except for medical equipment and fit-outs provided by the company.
  • No specific plans for external fundraising were indicated during the call or in the disclosed expansion updates.

See what Max Healthcare management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Mohali Hospital (250 beds): Built-to-suit 2.75 lakh sq.ft. facility on 50-year lease; developer funds land/building; company invests in medical equipment and fit-outs. Commission expected by FY28.
  • Lucknow Hospital: Refurbishing existing 250-bed facility; adding 140 beds by end FY24; new 450-bed tower with EC approval, expected completion within 24 months.
  • Nagpur Hospital: Adding 25 beds via reconfiguration by Q3 FY25; EC approval filed for 115 additional beds, expected completion in 24 months.
  • Nanavati Hospital (Phase I): New 241-bed structure expected to be completed by FY25 end; project on schedule.
  • Max Smart (Saket Complex): 375-bed steel structure building fast-tracked; completion expected by Q1 FY26.
  • Expansion mostly funded through internal accruals, following an asset-light strategy minimizing development risks.

Track Max Healthcare — get its next earnings analysis in your feed

How does Max Healthcare rank vs peers in Healthcare Services?

Pro feature
ThisMax Healthcare
Rev 3Mar 4

How does Max Healthcare rank in Healthcare Services?

Compare Max Healthcare against every Healthcare Services company (Q1 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →